Phase I/II trial of AMT-130 gene therapy for Huntington’s disease reports slowed disease progression versus natural history cohort 🧬🧠📉
Read Full Article
#HuntingtonsDisease #GeneTherapy #AMT130 #ClinicalTrials #HealthInnovation
Read Full Article
#HuntingtonsDisease #GeneTherapy #AMT130 #ClinicalTrials #HealthInnovation
The BMJ
Huntington’s disease: new gene therapy explained
A gene therapy trial claims to show promising results for patients with Huntington’s disease. A press announcement of the experimental treatment suggests significant slowing of the disease over three years.
On 24 September, US biotechnology company uniQure…
On 24 September, US biotechnology company uniQure…